Application of Yokohama system for reporting breast Fine Needle Aspiration Cytology in correlation with histopathological and radiological findings

  • Murari Apuroopa Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinna Avutapalli, Gannavaram, AP, India
  • V Kalyan Chakravarthy Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinna Avutapalli, Gannavaram, AP, India
  • D Ranga Rao Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinna Avutapalli, Gannavaram, AP, India
Keywords: Ultrasound, Yokohama, PPV, NPV

Abstract

Background: Breast cancer is the leading cause of cancer deaths among women worldwide. Fine needle aspiration cytology (FNAC) and breast ultrasound are pivotal in characterization of a breast lump as benign and malignant lesion. The main objectives were to categorise the Breast FNAC samples according to new system of reporting and to assess the Risk of malignancy (ROM), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy for all categories. Methods: A Total of 900 FNAB cytology specimens from January 2017 to December 2018 were obtained. These were reclassified according to newly proposed IAC Yokohama system of reporting. The ROM, sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV) and diagnostic yield of Breast FNAC and also of ultrasound were calculated. Result: Among 900 cases, 4.3% fall in category 1, 58%- category 2, 17.7%- category 3, 7.2%- category 4 and 12.8% - category 5, and correlated with corresponding radiological impression. Sensitivity, specificity, PPV, NPV and diagnostic accuracy of ultrasound were respectively 91.6%, 96.8%, 95.6%, 92.8%, 91.5% and those of FNAC respectively 94.59%, 98.9%, 98.59%, 95.74%, 96.97%. ROM is 5.0% for category 1, 1.2% for category 2, 12.5% for category 3, 93.65% for category 4 and 100% for category 5. Conclusion: IAC Yokohama system of reporting breast cytopathology serves as a common language to pathologist and clinician. Breast ultrasound is a non-invasive imaging-based technique and both these diagnostic tools can complement each other for patient diagnosis and management.

Author Biographies

Murari Apuroopa, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinna Avutapalli, Gannavaram, AP, India
Dept of Pathology
V Kalyan Chakravarthy, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinna Avutapalli, Gannavaram, AP, India
Dept of Pathology
D Ranga Rao, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinna Avutapalli, Gannavaram, AP, India
Dept of Pathology

References

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0: IARC CancerBase No. 11. Lyon: International Agency for Research on Cancer; 2013.
2. Schmitt F, Vielh P. Fine needle aspiration cytology samples: a good source of material for evaluating biomarkers in breast cancer. Histopathology. 2015;66:314-3150.
3. McManus, DT. & Anderson, N.H. Fine needle aspiration cytology of the breast. Current DiagnosticPathology 2001;7:262-271Anderson BO. Fine needle aspiration for breast cancer diagnosis: one size does not fit all. J Natl Compr Canc Netw. 2016;14;599-600.
4. Rungruang B, Kelley JL 3rd. Benign breast diseases: epidemiology, evaluation, and management. Clin Obstet Gynecol. 2011 Mar; 54(1): 110–24.
5. Kreuzer G, Boquoi E. Aspiration biopsy cytology, mammography and clinical exploration: a modern set up in diagnosis of tumors of the breast. Acta Cytol. 1976 Jul–Aug; 20(4): 319– 23.
6. Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y, et al. A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. Ann Surg Oncol. 2013 Mar; 20(3): 850– 5.
7. Wells CA, Perera R, White FE, Domizio P. Fine needle aspiration cytology in the UK breast screening programme: a national audit of results. Breast. 1999 Oct; 8(5): 261–6.
8. Pisano ED, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators. Cancer. 1998 Feb; 82(4): 679–88.
9. Pisano ED, Fajardo LL, Caudry DJ, Sneige N, Frable WJ, Berg WA, et al. Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. Radiology. 2001 Jun; 219(3): 785–92.
10. Field AS, Schmitt F, Vielh P. IAC standardized reporting of breast fine-needle aspiration biopsy cytology. Acta Cytol. 2017; 61(1): 3–6.
11. Montezuma D, Malheiros D, Schmitt FC. Breast Fine needle aspiration biopsy [7] cytology using the newly proposed IAC Yokohama system for reporting breast cytopathology: The experience of a single institution. Acta Cytol. 2019;63(Suppl.4):274-79.
12. Wong S, Rickard M, Earls P, Arnold L, Bako B, Field AS. The International [8] Academy of Cytology Yokohama System for reporting breast fine needle aspiration biopsy cytopathology: A single institutional retrospective study of the application of the system categories and the impact of rapid onsite evaluation. Acta Cytol. 2019;63(Suppl.4):280-91.
13. Kamatar PV et al., Breast Fine needle Aspiration Biopsy Cytology Reporting using International Academy of Cytology Yokohama SystemTwo Year Retrospective Study in Tertiary Care Centre in Southern India. National Journal of Laboratory Medicine. 2019 Oct, Vol-8(3): PO01-PO03.
14. Moschetta M. Comparison between fine needle aspiration cytology (FNAC) [9] and core needle biopsy (CNB) in the diagnosis of breast lesions. G Chir- J Surg [Internet]. 2014 [cited 2019 Jul 17]; Available from: http://www.giornalechirurgia. it/common/php/portiere.php?ID=73366646a0b094bb6a480507c74c39ea
15. Heinig J, Witteler R, Schmitz R, Kiesel L, Steinhard J. Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS. Ultrasound Obstet Gynecol. 2008; 32:573–78.
16. Wasan et al: Non Palpable Breast Mass. Mustansiriya Medical Journal Volume 15 Issue 1 April 201.
17. Nandan Kumar1, Shilpa N et al. Mammographic And Sonomammographic Evaluation Of Breast Masses With Pathological Correlation. Innovative Journal of Medical and Health Science 2016;6:132 – 135.
Published
2020-05-02
Section
Original Article